Surgeons carry out 1,000th operation using a surgical robot at Sunderland Royal Hospital
Surgeons at Sunderland Royal Hospital have reached a major milestone - successfully completing 1,000 operations using a surgical robot.
A dedicated team of surgeons, nurses, and anaesthetists began using the robot in 2013 for treating kidney and prostate cancers. Since then, they have expanded its use for cancers of the bladder, bowel, and head and neck.
Through the da Vinci system, the surgeon sees 3D images of the inside of the patient’s body and controls the robot’s ‘arms’ with pinpoint accuracy to carry out advanced laparoscopic (keyhole) surgery.
The robotic instruments are very small, around 8mm in size, and can bend and rotate in a similar fashion to the human wrist, allowing for more precise operation.
Consequently, there is less scarring, less pain and a much faster recovery time, with fewer complications, allowing patients to continue after cancer with an improved quality of life.
The use of robotic surgery at Sunderland Royal has made a major contribution to improving the quality of services and care provided to patients, including revolutionising urological cancer surgery at the hospital, thereby improving surgical outcomes and the quality of life for patients in Sunderland, South Tyneside, North Durham and Bishop Auckland.
Urology Consultant Mr Kanagasabai Sahadevan, who set up the service at Sunderland Royal along with his colleagues, said: “Establishing robot surgery has been a very rewarding experience and the team are incredibly proud to be providing this service and to have reached the landmark of 1,000 cases.
Sign up to our daily newsletter
The i newsletter cut through the noise
"Our local population can be assured that, in Sunderland Royal, they have a world-class robotic surgery centre of excellence.
“We are very grateful to City Hospitals Sunderland NHS Foundation Trust’s Board for their support for this exciting development which is giving patients such great benefits."
Having personally performed more than 500 robotic surgeries, Mr Sahadevan is now expanding the use of the robot to perform even more complex procedures.
In the last published National Prostate Cancer Audit, the Trust performed better than the national average and was the best performer in the region for re-admissions and urinary complications after radical prostatectomy (surgery to remove the prostate gland and tissues surrounding it).
The Trust is also a national leader in keeping the length of stay short for patients who undergo bladder removal for bladder cancer.
In addition, the Trust has one of the most structured robotic colorectal surgical programmes in the North of England, and the head and neck cancer team are able to offer complex robotic procedures which are only available in a select few centres in the country.